Deuteroncology

Developer of therapeutics for lung cancer

placeLiege, Wallonia, Belgium calendar_todayFounded 2020 groups4 employees language deuteroncology.com

Registered entities

Social engagement

Social engagement: 596 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Private equity125%
Coming soon